Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial-Reference-Cited by-同舟云学术

Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial

Published:2024-04 Issue: Volume: Page:
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Popolo Rubbio Antonio,Testa Luca,Pivato Carlo A.,Regazzoli Damiano,Piccolo Raffaele,Esposito Giovanni,Musto Carmine,Scalia Lorenzo,Pacchioni Andrea,Briguori Carlo,Lucisano Luigi,De Luca Leonardo,Conrotto Federico,Tartaglia Francesco,Latini Alessia C.,Stankowski Kamil,Chiarito Mauro,Sardella Gennaro,Indolfi Ciro,Bedogni Francesco,Reimers Bernhard,Condorelli Gianluigi,Stefanini Giulio G.

Funder

Boston Scientific Corporation

Publisher

Elsevier BV

Reference32 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;Valgimigli;Eur Heart J,2018

2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

3. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside;Nicolas;Cardiovasc Res,2022

4. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials;Costa;Eur Heart J,2022

5. Short duration of DAPT versus De-escalation after percutaneous coronary intervention for acute coronary syndromes;Laudani;JACC Cardiovasc Interv,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials;European Heart Journal Open;2024-07

2. Editorial: Short-term DAPT after bioabsorable polymer synergy stents;Cardiovascular Revascularization Medicine;2024-06